Oct 9, 2023 by James HalleyWhy Shares of Tango Therapeutics Are Dropping MondayAnother company's buyout helped drive up the price last week. This week, investors started out by selling the stock.
Oct 8, 2023 by James HalleyWhich Is the Better Cancer-Testing Healthcare Stock: Exact Sciences or Guardant Health?The oncology diagnostic companies are looking for better solutions in early cancer diagnosis.
Oct 7, 2023 by James HalleyIs Editas Stock a Buy Now?Shares of the gene-editing company are close to their 52-week lows. Does it make sense to buy the stock now?
Oct 6, 2023 by James HalleyWhy Shares of Agiliti Dropped This WeekThe company replaced its CEO with a former CEO early in the week.
Oct 6, 2023 by James HalleyWhy Shares of Cassava Sciences Soared This WeekCassava bounced back from hitting a 52-week low to start the week.
Oct 6, 2023 by James HalleyWhy Shares of Koninklijke Philips Are Falling on FridayThe FDA is requiring more testing regarding the company's recall of sleep apnea and respiratory products.
Oct 6, 2023 by James HalleyWhy Shares of Accolade Fell This WeekThe company's fiscal 2024 second-quarter numbers showed improvement, but analysts and investors were not impressed.
Oct 5, 2023 by James HalleyWhy Shares of uniQure Are Up ThursdayThe company announced a reorganization that included layoffs.
Oct 5, 2023 by James HalleyWhy Shares of MaxCyte Are Plummeting on ThursdayThe biotech company reduced full-year guidance and expects so-so third-quarter revenue.
Oct 5, 2023 by James Halley3 Top Pot Stocks to Watch in OctoberThree big multi-state operators that are strong enough to thrive for years.
Oct 4, 2023 by James HalleyWhy Nuvalent Stock Was Soaring WednesdayThe company reported preliminary data on a non-small cell lung cancer therapy.
Oct 4, 2023 by James HalleyWhy Shares of Conduit Pharmaceuticals Are Jumping WednesdayThe stock had a brief big rebound from a huge drop on Tuesday.
Oct 3, 2023 by James HalleyWhy Shares of Enhabit Slumped on TuesdayThe company received a waiver for a potential covenant breach with its lenders.
Oct 3, 2023 by James HalleyWhy Shares of Kymera Therapeutics Jumped on TuesdayThe company had a big bounce after hitting a 52-week low the day before.
Oct 3, 2023 by James HalleyWhy Shares of Point Biopharma Global Are Soaring TuesdayThe company entered into a buyout agreement with Eli Lilly.
Oct 3, 2023 by James Halley3 Healthcare Stocks to Keep an Eye OnThese three lesser-known healthcare companies have strong growth potential.
Oct 2, 2023 by James HalleyWhy Shares of Structure Therapeutics Are Up MondayThe stock climbed for the second straight day after the company reported positive trial data for its weight-loss therapy drug.
Oct 2, 2023 by James HalleyWhy Shares of Avita Medical Are Down MondayThe company's potential launch of a new device will likely be pushed back.
Oct 2, 2023 by James HalleyWhy Shares of Danaher Are Down MondayThe conglomerate has completed the spinoff of its environmental and applied solutions segment into a new company, Veralto.
Sep 29, 2023 by James HalleyWhy Shares of Structure Therapeutics Are Soaring on FridayThe company reported positive results from an early-stage clinical trial for its weight-loss therapy candidate.
